A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease

  • Leong, Rupert, (Primary Chief Investigator)
  • Butala, Radhika, (Clinical Trial Unit Staff)
  • Chapman, Nicola, (Clinical Trial Unit Staff)
  • Parshionikar, Abhijit, (Clinical Trial Unit Staff)
  • Rajasekharan Nair, Archana, (Clinical Trial Unit Staff)

Project: Research

Short titleGALAXI
AcronymGALAXI
StatusActive
Effective start/end date30/09/197/05/24